Home » Sun Pharma Gets FDA Tentative Approval for Generic Rilutek
Sun Pharma Gets FDA Tentative Approval for Generic Rilutek
Sun Pharmaceutical Industries Ltd. announced that USFDA has granted a tentative approval for its ANDA to market a generic version of Sanofi Aventis’s Rilutek.
Forbes
Forbes
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May